Ratio of oxymatine to compound inhibition of mRNA expression in human HepG2(2.2.15) cells infected with Hepatitis B virus

Basic Information

ID: ALA1820549

Type: Functional

Description: Ratio of oxymatine to compound inhibition of mRNA expression in human HepG2(2.2.15) cells infected with Hepatitis B virus

Format: BAO_0000219

Organism: Homo sapiens

Cell type: HepG2 2.2.15

Target: HepG2 2.2.15(ALA4296438)

Document: ALA1817622

Ratio of oxymatine to compound inhibition of mRNA expression in human HepG2(2.2.15) cells infected with Hepatitis B virus: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA1820549

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
386.54	3.62	3.62

Parent Molecular Weight

ALogP

Polar Surface Area

386.54

3.62

Basic Information